Various stakeholders are involved in drug safety monitoring, including regulatory agencies like the FDA, pharmaceutical companies, healthcare providers, and patients. Regulatory agencies collect and analyze data on adverse drug reactions (ADRs) and enforce safety measures. Pharmaceutical companies conduct post-marketing surveillance and report findings. Healthcare providers report ADRs observed in clinical practice, and patients can report their experiences through various platforms.
